Koyani, Himanshu BharatkumarJain, AbhishekDeshpande, AbhinavJournal of Cancer Research & Therapeutics
thrombosis of the internal jugular vein due to a spontaneous migration of a Port-A-Cath catheter into the ipsilateral internal jugular vein as a delayed complication of a central venous access catheter implanted for chemotherapy delivery. ... M Binneb?Sel,J Grommes,K Junge,... - 《Cases Jour...
Since the introduction of the port system by Niederhuber et al.1, the use of chemoports in patients undergoing chemotherapy has increased considerably. The use of chemoports has enabled the safe administration of high-vesicant chemotherapeutic drugs. In addition, it can be used for parenteral nutr...
One randomized controlled study regarding tunnelling in patients who had undergone chemotherapy [19]. However, they assessed a relatively small number of participants (n = 129) and limited the study population to cancer patients. Thus, a prospective and randomized controlled study is needed to ...
Subcutaneous chemoport placement is a preferred long term venous access for cancer chemotherapy. These totally implantable devices are plastic or metallic ... Harish 被引量: 0发表: 0年 Insertion of a Sacral Neuromodulation Device subcutaneous pockettest stimulation leadThis chapter offers practicing and...
The totally implantable venous access port (TIVAP) is an important device in patients for injecting blood products, parenteral nutrition or antineoplastic chemotherapy. Metastatic spread at the site of the insertion of a TIVAP is extremely rare. ...
The implantation of permanent (> 14 days) central venous catheters is constantly increasing, accelerated by a trend toward outpatient therapies. Subcutaneous tunneled and non-tunneled catheters as well as port systems are available. The ... UKM Teichgräber,B Gebauer,T Benter,... - 《Röfo...
Totally implantable venous access port (TIVAP) implantation was first introduced in the early 1980s by Niederhuber et al. [1]. Following further refinement, the technique has been adopted worldwide to create a safe and permanent venous access for chemotherapy (CHT) and/or parenteral nutrition. ...
This was a prospective, multicenter cohort study in children with acute lymphoblastic leukemia who had a CVL placed in the upper venous system during induction chemotherapy. Characteristics of CVL were documented prospectively. All children had outcome assessment for VTE by objective radiographic tests,...
Chemotherapy access measures in cancer patients can be done through 2 (two) ways, using abocath as peripheral intravenous access and insertion of chemoport under the skin. For patients undergoing chemotherapy with long treatment durations, it is necessary to use chemoports to prevent patients...